Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

NCT03073109 · clinicaltrials.gov ↗
COMPLETED
Status
170
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer